Cell line-specific network models of ER+ breast cancer identify PI3Kα inhibitor sensitivity factors and drug combinations
Jorge Gómez Tejeda Zañudo(Broad Institute), Nikhil Wagle(Dana-Farber Cancer Institute)
Cited by 2
Related Papers
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine
|Nature Medicine|2014|571
High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing
|Cancer Discovery|2011|539
MAP Kinase Pathway Alterations in <i>BRAF</i> -Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
|Cancer Discovery|2013|473
A p53-Dependent Checkpoint Pathway Prevents Rereplication
|Molecular Cell|2003|390
Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer
|New England Journal of Medicine|2014|327